The $100 Million Liraglutide Pivot: Why Biocon Is Prioritising US Exports Over The Indian Price War

While Liraglutide provides immediate momentum, the industry is eyeing 2031, the year Semaglutide patents expire in the US and Europe.

Related Posts

Globe Civil Projects Limited Secures Rs 98.85 Crore Res...

Nidhi Mishra Feb 28, 2026  0

India's Economic Activity Accelerates In February On Lo...

rvrising Feb 20, 2026  0

T20 World Cup Final: Jasprit Bumrah, Axar Patel Dent Ne...

rvrising Mar 8, 2026  0

Comments

Name

Email

Comment

Post Comment